Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet GODT SMIL KOLDING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.0% 1.0% 2.0% 3.1% 1.1% 5.3% 12.5% 12.3%   Credit score (0-100)   89 87 68 54 85 41 19 19   Credit rating   A A A BBB A BBB BB BB   Credit limit (kDKK)   356.2 318.0 0.6 0.0 224.6 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,485 11,892 13,259 16,535 12,598 10,967 0.0 0.0   EBITDA   1,789 2,593 2,477 3,978 1,188 186 0.0 0.0   EBIT   1,112 1,884 1,756 3,474 909 -71.2 0.0 0.0   Pre-tax profit (PTP)   1,114.7 1,890.9 1,734.7 3,438.0 872.7 -98.1 0.0 0.0   Net earnings   867.5 1,475.5 1,350.5 2,678.0 678.8 -76.6 0.0 0.0   Pre-tax profit without non-rec. items   1,115 1,891 1,735 3,438 873 -98.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,844 1,515 1,176 963 842 732 0.0 0.0   Shareholders equity total   2,128 2,104 954 1,132 1,561 734 609 609   Interest-bearing liabilities   116 113 283 163 41.4 0.0 0.0 0.0   Balance sheet total (assets)   4,294 4,756 4,386 4,854 3,632 2,842 609 609   Net Debt   -1,111 -1,445 -1,208 -2,157 -1,098 -593 -609 -609     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,485 11,892 13,259 16,535 12,598 10,967 0.0 0.0   Gross profit growth   0.7% 3.5% 11.5% 24.7% -23.8% -12.9% -100.0% 0.0%   Employees   14 15 17 18 17 16 0 0   Employee growth %   0.0% 7.1% 13.3% 5.9% -5.6% -5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,294 4,756 4,386 4,854 3,632 2,842 609 609   Balance sheet change%   -5.2% 10.8% -7.8% 10.7% -25.2% -21.7% -78.6% 0.0%   Added value   1,789.3 2,592.9 2,477.4 3,978.0 1,412.8 186.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -938 -1,038 -1,060 -718 -400 -368 -732 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.7% 15.8% 13.2% 21.0% 7.2% -0.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.7% 42.2% 38.8% 75.5% 21.6% -1.8% 0.0% 0.0%   ROI %   44.8% 71.4% 79.1% 192.2% 53.0% -5.1% 0.0% 0.0%   ROE %   39.5% 69.7% 88.3% 256.7% 50.4% -6.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.9% 46.6% 23.6% 24.5% 45.5% 27.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -62.1% -55.7% -48.8% -54.2% -92.5% -318.4% 0.0% 0.0%   Gearing %   5.5% 5.4% 29.6% 14.4% 2.7% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   18.9% 16.5% 20.4% 23.5% 41.6% 186.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.3 1.0 1.1 1.5 1.0 0.0 0.0   Current Ratio   1.4 1.5 1.2 1.2 1.8 1.4 0.0 0.0   Cash and cash equivalent   1,227.3 1,557.9 1,490.9 2,320.4 1,139.7 593.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   630.4 1,029.0 436.9 714.3 1,229.2 536.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   128 173 146 221 83 12 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   128 173 146 221 70 12 0 0   EBIT / employee   79 126 103 193 53 -4 0 0   Net earnings / employee   62 98 79 149 40 -5 0 0